|
|||||
|
|
Leuprorelin: a leading role in advanced prostate cancer therapy |
|
| Authors: | Persad Raj |
| Affiliation: | Bristol Royal Infirmary, University of Bristol. |
| Abstract: | Leuprorelin is a luteinizing hormone-releasing hormone analogue, licensed in the UK for the treatment of advanced prostate cancer. This review highlights the efficacy and tolerance of this agent and the benefits provided for developing patient-centred therapy and optimizing patient quality of life. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |